Organisation paid for research Program year 2024 Source: CMS Open Payments

Admed Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$385,017

33 payments

Through program year 2024, Admed Research, LLC is reported as receiving $385,017 in research payments, across 33 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2024	Research	$115,451	1
2023	Research	$226,782	26
2022	Research	$42,784	6

Breakdown

Who paid Research payments · program years 2022–2024

Organon LLC $300,633 32 payments
AstraZeneca Pharmaceuticals LP $84,384 1 payment

Studies the money was for Research payments · program years 2022–2024

Og-8175A-023 $158,235 7 payments
Og-8175A-023 $142,399 25 payments
A Double Blind Placebo Controlled Multicenter Study to Evaluate the Efficacy and Safety of Multiple Dose Strengths of CIN 107 as Compared to Placebo After 8 Weeks of Treatment in Patients With Uncontrolled Hypertension $84,384 1 payment

What the money was spent on Research payments · program years 2022–2024

Patient care $300,633 32 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.